# A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male Participants

> **NCT01655147** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 19 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Abiraterone acetate
- **DRUG:** Rifampicin

## Key facts

- **NCT ID:** NCT01655147
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2013-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01655147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01655147, "A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Abiraterone in Healthy Male Participants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01655147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*